Daxeshkumar P. Patel, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 37, Room 3060
- Bethesda, MD 20892
- 240-760-7282
- daxeshkumar.patel@nih.gov
Staff Scientist
RESEARCH SUMMARY
Daxeshkumar P. Patel, Ph.D., is a Staff Scientist at the National Cancer Institute (NCI), NIH, specializing in computational biology, analytical chemistry, and multiomics research. He employs advanced mass spectrometry and machine learning to investigate biomarkers such as creatine riboside and 561.3+m/z, uncovering molecular mechanisms in liver and lung cancers. His work focuses on pathway analyses, novel biomarker characterization, and precision medicine strategies, driving innovations in early cancer diagnostics and therapeutic development for metabolic disorders. Dr. Patel’s expertise bridges molecular biology and bioinformatics, advancing the frontiers of cancer research and personalized medicine.
Areas of Expertise
Molecular Mechanisms of Cancer
Cancer Metabolism
Diagnostics and Biomarkers
Precision Medicine
Computational Biology
Epidemiology
Daxeshkumar P. Patel, Ph.D.
Publications
- Bibliography Link
- Google Scholar
Selected Key Publications
Associations of chronic liver disease and liver cancer with glyphosate and its metabolites in Thailand
Int J Cancer.
1-13,
2024.
[ Journal Article ]
Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis
Hepatology.
1;77(1):
239-255,
2023.
[ Journal Article ]
Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy
J Clin Invest.
15;132(14):
e157410,
2022.
[ Journal Article ]
Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
J Pharmacol Exp Ther..
371(2):
360-374,
2019.
[ Journal Article ]
Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota
Cell Metab..
26(4):
672-685,
2017.
[ Journal Article ]